Dallas, TX, September 25, 2024 <\/strong>\u2013 US ENT Partners announced a new partnership with ProSomnus Sleep Technologies, the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy\u2122. This collaboration represents a significant advancement in providing Medical and Dental Sleep Medicine team members with cutting-edge therapy solutions designed to enhance OSA patient care and improve practice efficiency.<\/p>\n\n\n\n “This new alignment between US ENT & ProSomnus, a leader in Oral Appliance Therapy for Obstructive Sleep Apnea, dramatically extends the reach for our Member Practices to provide this effective option for their sleep apnea patients,\u201d stated Keith E. Matheny, MD, FARS, Chairman & Chief Executive Officer for US ENT Partners.<\/p>\n\n\n\n \u201cProSomnus is proud to partner with US ENT to expand access to care for the tens of millions of US adults suffering from Obstructive Sleep Apnea. US ENT has an impressive record of aligning with technological innovations that lower total treatment costs and enable member physicians to spend more time on patient care. ProSomnus precision Oral Appliance Therapy devices, in collaboration with leading Dental Sleep Medicine Providers, have clinically and scientifically demonstrated effective, safe and economical care for patients diagnosed with OSA,\u201d stated Len Liptak, Chief Executive Office for ProSomnus Sleep Technologies.<\/p>\n\n\n\n This partnership with ProSomnus is expected to bring significant value to ENT practices, enabling them to offer the highest standard of care to patients with sleep apnea. For more information, visit US ENT at booth #2311 at the AAO-HNSF 2024 Annual Meeting & OTO EXPO taking place September 28-October 1 in Miami Beach, FL.<\/p>\n\n\n\n Our founders, Keith Matheny and Jeff Gallant, established US ENT with a clear vision: to save ear, nose, and throat practices both time and money, allowing doctors and staff to focus on their patients. At US ENT, we strive to enhance practice operations, elevate patient care, and position ourselves as an industry-leading partner in the field of otolaryngology. To learn more, visit https:\/\/usent.com\/.<\/p>\n\n\n\n ProSomnus Sleep Technologies is the leading non-CPAP therapy for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government-sponsored healthcare plans around the world, representing over 200 million covered lives. To learn more, visit www.ProSomnus.com.<\/p>\n\n\n\n James Hermansen Heather Whalen US ENT Partners Announces Partnership with ProSomnus\u00ae Sleep Technologies to Advance Sleep Apnea Care Dallas, TX, September 25, 2024 \u2013 US ENT Partners announced a new partnership with ProSomnus Sleep Technologies, the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy\u2122. This collaboration represents a significant advancement in providing Medical and Dental Sleep Medicine team members with…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","schema":"","fname":"","lname":"","position":"","credentials":"","placeID":"","no_match":false,"name":"","company":"","review":"","address":"","city":"","state":"","zip":"","lat":"","lng":"","phone1":"","phone2":"","fax":"","mon1":"","mon2":"","tue1":"","tue2":"","wed1":"","wed2":"","thu1":"","thu2":"","fri1":"","fri2":"","sat1":"","sat2":"","sun1":"","sun2":"","hours-note":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/posts\/959"}],"collection":[{"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/comments?post=959"}],"version-history":[{"count":2,"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/posts\/959\/revisions"}],"predecessor-version":[{"id":963,"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/posts\/959\/revisions\/963"}],"wp:attachment":[{"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/media?parent=959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/categories?post=959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/usent.com\/wp-json\/wp\/v2\/tags?post=959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Key Benefits of the Partnership:<\/h2>\n\n\n\n
\n
\n
\n
\n
About US ENT Partners<\/h2>\n\n\n\n
About ProSomnus Sleep Technologies<\/h2>\n\n\n\n
Media Contacts<\/h2>\n\n\n\n
US ENT Partners
Email: Jhermansen@usentpartners.com<\/a>
Phone: +1.612.965.4890<\/a><\/p>\n\n\n\n
ProSomnus Sleep Technologies
Email: HWhalen@ProSomnus.com<\/a>
Phone: +1.925.360.2990<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"